Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · November 07, 2024

Effects of Semaglutide Use on Obesity in Patients Undergoing Dialysis for Kidney Failure

Diabetes, Obesity & Metabolism

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Semaglutide in patients with kidney failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open-label study
Diabetes Obes Metab 2024 Oct 07;[EPub Ahead of Print], L Vanek, A Kurnikowski, S Krenn, S Mussnig, M Hecking

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading